Capvizr
THE DEAL, AT A GLANCE

Xeltis

From the announcement
01What happenedXeltis raised $23.3M, announced 2026-07-28From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
02Why it mattersXeltis' $23.3M financing is a mid-lower percentile Healthcare & Life Sciences capital event tied to bringing its vascular access device to the US market, with the round…From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

Xeltis · Financing Record

Explore source-linked visual explanations for Xeltis. Unsupported claims are withheld while source review continues.

Record 9152 · Recorded date: 2026-07-28

What it does

Xeltis, image from xeltis.com

Xeltis is an an international medtech company with business with roots in the Netherlands and commercial and clinical operations throughout Europe and the US.

Source: xeltis.com ↗

Open record 9152 →

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime